Gastrointestinal issues in the assessment and management of the obese patient

Gastroenterology and Hepatology

Volumn 3, Issue 7, 2007, Pages 559-569

  Hussain, Zulfiqar ^c   Quigley, Eamonn M M ^a,b,c  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b Department of Medicine National University of Ireland Cork   (Ireland)

^c Clinical Sciences Building ^*

Author keywords

Bariatric surgery gastrointestinal endoscopy; Gastrointestinal cancer; Gastrointestinal hemorrhage; GERD; Obesity

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

BALLOON; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; CANCER; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; ENDOSCOPY; EPIDEMIC; ESOPHAGEAL ADENOCARCINOMA; GALLBLADDER DISEASE; GALLSTONE; GASTRECTOMY; GASTRIC BANDING; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TRACT; GASTROPLASTY; HUMAN; JEJUNOILEAL BYPASS; LIVER DISEASE; LUNG EMBOLISM; MEDICAL SPECIALIST; OBESITY; PANCREATITIS; PATIENT CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PREVALENCE; REVIEW; RHABDOMYOLYSIS; RISK BENEFIT ANALYSIS; ROUX Y ANASTOMOSIS; STOMACH BYPASS; TREATMENT INDICATION; TREATMENT PLANNING; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION; WOUND INFECTION;

EID: 34547786839     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (149)

1. Allison DB, Fontaine KR, Manson JE, et al. Annual deaths attributable to obesity in the United States. JAMA. 1999;282:1530-1538.
2. Klein S, Wadden T, Sugerman HJ. AGA technical review on obesity. Gastroenterology. 2002;123:882-932.
3. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444:1022-1023.
4. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults - The Evidence Report. National Institutes of Health. Obes Res. 1998;6:(suppl 2)51S-209S.
5. Cremonini F, Locke GR 3rd, Schleck CD, et al. Relationship between upper gastrointestinal symptoms and changes in body weight in a population-based cohort. Neurogastroenterol Motil. 2006;18:987-994.
6. Ronkainen J, Aro P, Storskrubb T, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol. 2005;40:275-285.
7. Aro P, Ronkainen J, Talley NJ, et al. Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study. Gut. 2005;54:1377-1383.
8. Talley NJ, Howell S, Poulton R. Obesity and chronic gastrointestinal tract symptoms in young adults: a birth cohort study. Am J Gastroenterol. 2004;99:1807-1814.
9. Delgado-Aros S, Locke GR 3rd, Camilleri M, et al. Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol. 2004;99:1801-1806.
10. Talley NJ, Quan C, Jones MP, Horowitz M. Association of upper and lower gastrointestinal tract symproms with body mass index in an Australian cohort. Neurogastroenterol Motil. 2004;16:413-419.
11. Foster A, Laws HL, Gonzalez QH, Clements RH. Gastrointestinal symptomatic outcome after laparoscopic Roux-en-Y gastric bypass. J Gastrointest Surg. 2003;7:750-753.
12. Ramaswamy A, Lin E, Ramshaw BJ, Smith CD. Early effects of Helicobacter pylori infection in patients undergoing bariatric surgery. Arch Surg. 2004;139:1094-1096.
13. Jackson SJ, Leahy FE, McGowan AA, et al. Delayed gastric emptying in the obese: an assessment using the non-invasive (13)C-octanoic acid breath test. Diabetes Obes Metab. 2004;6:264-270.
14. Vazquez Roque MI, Camilleri M, Stephens DA, et al. Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people. Gastroenterology. 2006;131:1717-1724.
15. Park MI, Camilleri M. Gastric motor and sensory functions in obesity. Obes Res. 2005;13:491-500.
16. Corley DA, Kubo A, Zhao W. Abdominal obesity, ethnicity, and gastroesophageal reflux disease. Gut. 2007;56:756-762.
17. Corley DA, Kubo A. Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Gastroenterol. 2006;101:2619-2628.
18. Lagergren J, Bergstrom R, Nyren O. No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut. 2000;47:26-29.
19. El-Serag HB, Graham DY, Satia JA, Rabeneck L. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol. 2005;100:1243-1250.
20. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143:199-211.
21. Fisher BL, Pennathur A, Mutnick JL, Little AG. Obesity correlates with gastroesophageal reflux. Dig Dis Sci. 1999;44:2290-2294.
22. El-Serag HB, Ergun GA, Pandolfino J, et al. Obesity increases esophageal acid exposure. Gut. 2007;56:749-755.
23. Wu JC, Mui LM, Cheung CM, et al. Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology. 2007;132:883-889.
24. Pandolfino JE, El-Serag HB, Zhang Q, et al. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology. 2006;130:639-649.
25. Fraser-Moodie CA, Norton B, Gornall C, et al. Weight loss has an independent beneficial effect on symptoms of gastro-oesophageal reflux in patients who are overweight. Scand J Gastroenterol. 1999;34:337-340.
26. Quiroga E, Cuenca-Abente F, Flum D, et al. Impaired esophageal function in morbidly obese patients with gastroesophageal reflux disease: evaluation with multichannel intraluminal impedance. Surg Endosc. 2006;20:739-743.
27. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med. 1999;130:883-890.
28. Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15:872-878.
29. Samanic C, Chow WH, Gridley G, et al. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control. 2006;17:901-909.
30. Ryan AM, Rowley SP, Fitzgerald AP, et al. Adenocarcinoma of the esophagus and gastric cardia: male preponderance in association with obesity. Eur J Cancer. 2006;42:1151-1158.
31. Lagergren J. Controversies surrounding body mass, reflux, and risk of oesophageal adenocarcinoma. Lancet Oncol. 2006;7:347-349.
32. McMillan DC, Sattar N, McArdle CS. ABC of obesity. Obesity and cancer. BMJ. 2006;333:1109-1111.
33. El-Serag HB. Obesity and disease of the esophagus and colon. Gastroenterol Clin North Am. 2005;34:63-82.
34. Maclure KM, Hayes KC, Colditz GA, et al. Weight, diet, and the risk of symptomatic gallstones in middle-aged women. N Engl J Med. 1989;321:563-569.
35. Stampfer MJ, Maclure KM, Colditz GA, et al. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr. 1992;55:652-658.
36. Tsai C-J, Leitzmann MF, Willett WC, Giovannucci EL. Central adiposity, regional fat distribution, and the risk of cholecystectomy in women. Gut. 2006;55:708-714.
37. Petroni ML. Review article: gall bladder motor function in obesity. Aliment Pharmacol Ther. 2000;14(suppl 2):48-50.
38. Vanek VW, Catania M, Triveri K, Woodruff RW Jr. Retrospective review of the preoperative biliary and gastrointestinal evaluation for gastric bypass surgery. Surg Obes Relat Dis. 2006;2:17-22.
39. Torgerson JS, Lindroos AK, Naslund I, Peltonen M. Gallstones, gallbladder disease, and pancreatitis: cross-sectional and 2-year data from the Swedish Obese Subjects (SOS) and SOS reference studies. Am J Gastroenterol. 2003;98:1032-1041.
40. Martinez J, Sanchez-Paya J, Palazon JM, et al. Is obesity a risk factor in acute pancreatitis? A meta-analysis. Pancreatology. 2004;4:42-48.
41. Martinez J, Johnson CD, Sanchez-Paya J, et al. Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: an updated meta-analysis. Pancreatology. 2006;6:206-209.
42. Papachristou GI, Papachristou DJ, Avula H, et al. Obesity increases the severity of acute pancreatitis: performance of APACHE-O score and correlation with the inflammatory response. Pancreatology. 2006;6:279-285.
43. Diehl AM. Hepatic complications of obesity. Gastroenterol Clin North Am. 2005;34:45-61.
44. Frezza EE, Wachtel MS, Chiriva-Internati M. The influence of obesity on the risk of developing colon cancer. Gut. 2006;55:285-291.
45. Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2006;98:920-931.
46. Gunter MJ, Leitzmann MF. Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes. J Nutr Biochem. 2006;17:145-156.
47. Rapp K, Schroeder J, Klenk J, et al. Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer. 2005;93:1062-1067.
48. Lukanova A, Bjor O, Kaaks R, et al. Body mass index and cancer: results from the Northern Sweden Health and Disease Cohort. Int J Cancer. 2006;118:458-466.
49. Almendingen K, Hofstad B, Vatn MH. Does high body fatness increase the risk of presence and growth of colorectal adenomas followed up in situ for 3 years? Am J Gastroenterol. 2001;96:2238-2246.
50. Morita T, Tabata S, Mineshita M, et al. The metabolic syndrome is associated with increased risk of colorectal adenoma development: the Self-Defense Forces health study. Asian Pac J Cancer Prev. 2005;6:485-489.
51. Meyerhardt JA, Catalano PJ, Haller DG, et al. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer. 2003;98:484-495.
52. Snow V, Barry P, Fitterman N, et al. Pharmacologic and surgical management of obesity in primary care: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2005;142:525-531.
53. Saltzman E, Anderson W, Apovian CM, et al. Criteria for patient selection and multidisciplinary evaluation and treatment of the weight loss surgery patient. Obes Res. 2005;13:234-243.
54. NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115:956-961.
55. Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004; 240:416-423.
56. Ballantyne GH. Measuring outcomes following bariatric surgery: weight loss parameters, improvement in co-morbid conditions, change in quality of life and patient satisfaction. Obes Surg. 2003;13:954-964.
57. Schirmer B, Erenoglu C, Miller A. Flexible endoscopy in the management of patients undergoing Roux-en-Y gastric bypass. Obes Surg. 2002;12:634-638.
58. Verset D, Houben JJ, Gay F, et al. The place of upper gastrointestinal tract endoscopy before and after vertical banded gastroplasty for morbid obesity. Dig Dis Sci. 1997;42:2333-2337.
59. Frigg A, Peterli R, Zynamon A, et al. Radiologic and endoscopic evaluation for laparoscopic adjustable gastric banding: preoperative and follow-up. Obes Surg. 2001;11:594-599.
60. Korenkov M, Sauerland S, Shah S, Junginger T. Is routine preoperative upper endoscopy in gastric banding patients really necessary? Obes Surg. 2006;16:45-47.
61. Sharaf RN, Weinshel EH, Bini EJ, etal. Endoscopy plays an important preoperative role in bariatric surgery. Obes Surg. 2004;14:1367-1372.
62. Azagury D, Dumonceau JM, Morel P, et al. Pteoperative work-up in asymptomatic patients undergoing Roux-en-Y gastric bypass: is endoscopy mandatory? Obes Surg. 2006;16:1304-1311.
63. Lujan JA, Frutos MD, Hernandez Q, et al. Laparoscopic versus open gastric bypass in the treatment of morbid obesity: a randomized prospective study. Ann Surg. 2004;239:433-437.
64. Podnos YD, Jimenez JC, Wilson SE, et al. Complications after laparoscopic gastric bypass: a review of 3,464 cases. Arch Surg. 2003;138:957-961.
65. Morino M, Toppino M, Bonnet G, del Genio G. Laparoscopic adjustable silicone gastric banding versus vertical banded gastroplasty in morbidly obese patients: a prospective randomized controlled clinical trial. Ann Surg. 2003;238:835-841.
66. Angrisani L, Furbetta F, Doldi SB, et al. Lap Band adjustable gastric banding system: the Italian experience with 1863 patients operated on 6 years. Surg Endosc. 2003;17:409-412.
67. Roman S, Napoleon B, Mion F, et al. Intragastric balloon for "non-morbid" obesity: a retrospecrive evaluation of tolerance and efficacy. Obes Surg. 2004;14:539-544.
68. Totte E, Hendrickx L, Pauwels M, Van Hee R. Weight reduction by means of intragastric device: experience with the bioenterics intragastric balloon. Obes Surg. 2001;11:519-523.
69. Sallet JA, Marchesini JB, Paiva DS, et al. Brazilian multicenter study of the intragastric balloon. Obes Surg. 2004;14:991-998.
70. Doldi SB, Micheletto G, Perrini MN, et al. Treatment of morbid obesity with intragastric balloon in association with diet. Obes Surg. 2002;12:583-587.
71. Evans JD, Scott MH. Intragastric balloon in the treatment of patients with morbid obesity. Br J Surg. 2001;88:1245-1248.
72. Regan JP, Inabnet WB, Gagner M, Pomp A. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003;13:861-864.
73. Mognol P, Chosidow D, Marmuse JP Laparoscopic sleeve gastrectomy as an initial bariatric operation for high-risk parients: initial results in 10 patients. Obes Surg. 2005;15:1030-1033.
74. Milone L, Strong V, Gagner M. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients. Obes Surg. 2005;15:612-617.
75. Nanni G, Balduzzi G, Botta C, et al. Biliopancreatic diversion. Clinical experience. Minerva Gastroenterol Dietol. 2005;51:209-212.
76. Ren CJ, Patterson E, Gagner M. Early results of laparoscopic biliopancreatic diversion with duodenal switch: a case series of 40 consecutive patients. Obes Surg. 2000;10:514-523.
77. Ovsiowitz M, Kanagarajan N, Ahmad AS. Endoscopic issues in the post-gastric bypass patient. Gastrointest Endosc Clin N Am. 2006;16:121-132.
78. Martin JA, Pandolfino JE. Gastrointestinal complications of bariatric surgery. Curr Gastroenterol Rep. 2005;7:321-328.
79. Kaplan LM. Gastrointestinal management of the bariatric surgery patient. Gastroenterol Clin North Am. 2005;34:105-125.
80. Weinsier RL, Wilson LJ, Lee J. Medically safe rate of weight loss for the treatment of obesity: a guideline based on risk of gallstone formation. Am J Med. 1995;98:115-117.
81. Al-Jiffry BO, Shaffer EA, Saccone GT, et al. Changes in gallbladder motility and gallstone formation following laparoscopic gastric banding for morbid obesity. Can J Gastroenterol. 2003;17:169-174.
82. Villegas L, Schneider B, Provost D, et al. Is routine cholecystectomy required during laparoscopic gastric bypass? Obes Surg. 2004;14:60-66.
83. Sanyal AJ, Sugerman HJ, Kellum JM, et al. Stomal complications of gastric bypass: incidence and outcome of therapy. Am J Gastroenterol. 1992;87:1165-1169.
84. Barba CA, Butensky MS, Lorenzo M, Newman R. Endoscopic dilation of gastroesophageal anastomosis stricture after gastric bypass. Surg Endosc. 2003;17:416-420.
85. Oczkowski WJ, Kertesz A. Wernicke's encephalopathy after gastroplasty for morbid obesity. Neurology. 1985;35:99-101.
86. Melinek J, Livingston E, Cortina G, Fishbein MC. Autopsy findings following gastric bypass surgery for morbid obesity. Arch Pathol Lab Med. 2002;126:1091-1095.
87. Sugerman HJ, Sugerman EL, Wolfe L, et al. Risks and benefits of gastric bypass in morbidly obese patients with severe venous stasis disease. Ann Surg. 2001;234:41-46.
88. Wu EC, Barba CA. Current practices in the prophylaxis of venous thromboembolism in bariatric surgery. Obes Surg. 2000;10:7-13.
89. Pories WJ, van Rij AM, Burlingham BT, et al. Prophylactic cefazolin in gastric bypass surgery. Surgery. 1981;90:426-432.
90. Khurana RN, Baudendistel TE, Morgan EF, et al. Postoperative rhabdomyolysis following laparoscopic gastric bypass in the morbidly obese. Arch Surg. 2004;139:73-76.
91. Nguyen NT, Longoria M, Chalifoux S, Wilson SE. Gastrointestinal hemorrhage after laparoscopic gastric bypass. Obes Surg. 2004;14:1308-1312.
92. Madan AK, Kuykendall SJ 4th, Ternovits CA, Tichansky DS. Mallory-Weiss tear after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2005;1: 500-502.
93. De Roover A, Detry O, Desaive C, et al. Risk of upper gastrointestinal cancer after bariatric operations. Obes Surg. 2006;16:1656-1661.
94. Freeman HJ. Risk of gastrointestinal malignancies and mechanisms of cancer development with obesity and its treatment. Best Pract Res Clin Gastroenterol. 2004;18:1167-1175.
95. Schneider BE, Villegas L, Blackburn GL, et al. Laparoscopic gastric bypass surgery: outcomes. J Laparoendosc Adv Surg Tech A. 2003;13:247-255.
96. Gonzalez R, Bowers SP, Venkatesh KR, et al. Preoperative factors predictive of complicated postoperative management after Roux-en-Y gastric bypass for morbid obesity. Surg Endosc. 2003;17:1900-1904.
97. Perugini RA, Mason R, Czerniach DR, et al. Predictors of complication and suboptimal weight loss after laparoscopic Roux-en-Y gastric bypass: a series of 188 patients. Arch Surg. 2003;138:541-545.
98. Papasavas PK, Caushaj PF, McCormick JT, et al. Laparoscopic management of complications following laparoscopic Roux-en-Y gastric bypass for morbid obesity. Surg Endosc. 2003;17:610-614.
99. Rossi TR, Dynda DI, Estes NC, Marshall JS. Stricture dilation after laparoscopic Roux-en-Y gastric bypass. Am J Surg. 2005;189:357-360.
100. Goitein D, Papasavas PK, Gagne D, et al. Gastrojejunal strictures following laparoscopic Roux-en-Y gastric bypass for morbid obesity. Surg Endosc. 2005;19:628-632.
101. Escalona A, Devaud N, Boza C, et al. Gastrojejunal anastomotic stricture after Roux-en-Y gastric bypass: ambulatory management with the Savary-Gilliard dilaror. Surg Endosc. 2007;21:765-768.
102. Wilson JA, Romagnuolo J, Byrne TK, et al. Predictots of endoscopic findings after Roux-en-Y gastric bypass. Am J Gastroenterol. 2006;101:2194-2199.
103. Ahmad J, Martin J, Ikramuddin S, et al. Endoscopic balloon dilation of gastroenteric anastomotic stricture after laparoscopic gastric bypass. Endoscopy. 2003;35:725-728.
104. Champion JK, Williams M. Small bowel obstruction and internal hernias after laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2003;13:596-600.
105. Merrifield BF, Lautz D, Thompson CC. Endoscopic repair of gastric leaks after Roux-en-Y gastric bypass: a less invasive approach. Gastrointest Endosc. 2006;63:710-714.
106. Carucci LR, Turner MA, Conklin RC, et al. Roux-en-Y gastric bypass surgery for morbid obesity: evaluation of postoperative extraluminal leaks with upper gastrointestinal series. Radiology. 2006;238:119-127.
107. Lyass S, Khalili TM, Cunneen S, et al. Radiological studies after laparoscopic Roux-en-Y gastric bypass: routine or selective? Am Surg. 2004;70:918-921.
108. Gonzalez R, Sarr MG, Smith CD, et al. Diagnosis and contemporary management of anastomotic leaks after gastric bypass for obesity. J Am Coll Surg. 2007;204:47-55.
109. Madan AK, Stoecklein HH, Ternovits CA, et al. Predictive value of upper gastrointestinal studies versus clinical signs for gastrointestinal leaks after laparoscopic gastric bypass. Surg Endosc. 2007;21:194-196.
110. Hamilton EC, Sims TL, Hamilton TT, et al. Clinical predictors of leak after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Surg Endosc. 2003;17:679-684.
111. Gumbs AA, Duffy AJ, Bell RL. Incidence and management of marginal ulceration after laparoscopic Roux-Y gastric bypass. Surg Obes Relat Dis. 2006;2:460-463.
112. Gumbs AA, Duffy AJ, Bell RL. Management of gastrogastric fistula after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006;2:117-121.
113. Carrodeguas L, Szomstein S, Soto F, et al. Management of gastrogastric fistulas after divided Roux-en-Y gastric bypass surgery for morbid obesity: analysis of 1,292 consecurive patients and review of literature. Surg Obes Relat Dis. 2005;1:467-474.
114. Awais O, Raftopoulos I, Luketich JD, Courcoulas A. Acute, complete proximal small bowel obstruction after laparoscopic gastric bypass due to intraluminal blood clot formation. Surg Obes Relat Dis. 2005;1:418-422.
115. Sakai P, Kuga R, Safatle-Ribeiro AV, et al. Is it feasible to reach the bypassed stomach after Roux-en-Y gastric bypass for morbid obesity? The use of the double-balloon enteroscope. Endoscopy. 2005;37:566-569.
116. Thompson CC, Slattery J, Bundga ME, Lautz DB. Peroral endoscopic reduction of dilated gastrojejunal anastomosis after Roux-en-Y gastric bypass: a possible new option for patients with weight regain. Surg Endosc. 2006;20:1744-1748.
117. Nosher JL, Bodner LJ, Girgis WS, et al. Percutaneous gastrostomy for treating dilatation of the bypassed stomach after bariatric surgery for morbid obesity. AJR Am J Roentgenol. 2004;183:1431-1435.
118. Martinez J, Guerrero L, Byers P, et al. Endoscopic retrograde cholangiopancreatography and gastroduodenoscopy after Roux-en-Y gastric bypass. Surg Endosc. 2006;20:1548-1550.
119. Foster A, Laws HL, Gonzalez QH, Clements RH. Gastrointestinal symptomatic outcome after laparoscopic Roux-en-Y gastric bypass. J Gastrointest Surg. 2003;7:750-753.
120. Huang CS, Forse RA, Jacobson BC, Farraye FA. Endoscopic findings and their clinical correlations in patients with symptoms after gastric bypass surgery. Gastrointest Endosc. 2003;58:859-866.
121. Suter M, Jayet C, Jayet A. Vertical banded gastroplasty: long-term results comparing three different techniques. Obes Surg. 2000;10:41-46.
122. Sataloff DM, Lieber CP, Seinige UL. Strictures following gastric stapling for morbid obesity. Results of endoscopic dilatation. Am Surg. 1990;56:167-174.
123. MacLean LD, Rhode BM, Sampalis J. Results of the surgical treatment of obesity. Am J Surg. 1993;165:155-162.
124. Evans JA, Williams NN, Chan EP, Kochman ML. Endoscopic removal of eroded bands in vertical banded gastroplasty: a novel use of endoscopic scissors (with video). Gastrointest Endosc. 2006;64:801-804.
125. Regusci L, Groebli Y, Meyer JL, et al. Gastroscopic removal of an adjustable gastric band after partial intragastric migration. Obes Surg. 2003;13:281-284.
126. Di Francesco V, Baggio E, Mastromauro M, et al. Obesity and gastroesophageal acid reflux: physiopathological mechanisms and role of gastric bariatric surgery. Obes Surg. 2004;14:1095-1102.
127. Ovrebo KK, Hatlebakk JG, Viste A, et al. Gastroesophageal reflux in morbidly obese patients treated with gastric banding or vertical banded gastroplasty. Ann Surg. 1998;228:51-58.
128. Ren CJ, Horgan S, Ponce J. US experience with the LAP-BAND system. Am J Surg. 2002;184:46S-50S.
129. Rubenstein RB. Laparoscopic adjustable gastric banding at a U.S. center with up to 3-year follow-up. Obes Surg. 2002;12:380-384.
130. DeMaria EJ. Laparoscopic adjustable silicone gastric banding: complications. J Laparoendosc Adv Surg Tech A. 2003;13:271-277.
131. Niville E, Dams A. Late pouch dilation after laparoscopic adjustable gastric and esophagogastric banding: incidence, treatment, and outcome. Obes Surg. 1999;9:381-384.
132. Gutschow CA, Collet P, Prenzel K, et al. Long-term results and gastroesophageal reflux in a series of laparoscopic adjustable gastric banding. J Gastrointest Surg. 2005;9:941-948.
133. Tolonen P, Victorzon M, Niemi R, Makela J. Does gastric banding for morbid obesity reduce or increase gastroesophageal reflux? Obes Surg. 2006;16:1469-1474.
134. Klaus A, Gruber I, Wetscher G, et al. Prevalent esophageal body motility disorders underlie aggravation of GERD symptoms in morbidly obese patients following adjustable gastric banding. Arch Surg. 2006;141:247-251.
135. de Jong JR, van Ramshorst B, Timmer R, et al. Effect of laparoscopic gastric banding on esophageal motility. Obes Surg. 2006;16:52-58.
136. Suter M, Dorta G, Giusti V, Calmes JM. Gastric banding interferes with esophageal motility and gastroesophageal reflux. Arch Surg. 2005;140:639-643.
137. Genco A, Bruni T, Doldi SB, et al. BioEnterics intragastric balloon: the Italian experience with 2,515 patients. Obes Surg. 2005;15:1161-1164.
138. Eynden FV, Urbain P. Small intestine gastric balloon impaction treated by laparoscopic surgery. Obes Surg. 2001;11:646-648.
139. Deitel M, Shahi B, Anand PK, et al. Long-term outcome in a series of jejunoileal bypass patients. Obes Surg. 1993;3:247-252.
140. Drenick EJ, Fisler J, Johnson D. Hepatic steatosis after intestinal bypass-prevention and reversal with metronidazole, irrespective of protein-calorie malnutrition. Gastroenterology. 1982;82:535-548.
141. Griffen WO, Bivins BA, Bell RM. The decline and fall of the jejunoileal bypass. Surg Gynecol Obstet. 1983;157:301-308.
142. Scopinaro N, Adami GF, Marinari GM. Biliopancreatic diversion. World J Surg. 1998;22:936-946.
143. Genco A, Cipriano M, Bacci V, et al. BioEnterics Intragastric Balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients. Int J Obes. 2006;30:129-133.
144. Hu B, Chung SC, Sun LC, et al. Transoral obesity surgery: endoluminal gastroplasty with an endoscopic suture device. Endoscopy. 2005;37:411-414.
145. Awan AN, Swain CP. Endoscopic vertical band gastroplasty with an endoscopic sewing machine. Gastrointest Endosc. 2002;55:254-256.
146. Ouyang H, Yin J, Chen JD. Gastric of intestinal electrical stimulation-induced increase in gastric volume is correlated with reduced food intake. Scand J Gastroenterol. 2006;41:1261-1266.
147. Miller K, Hoellet E, Aigner F. The implantable gastric stimulator for obesity: an update of the European experience in the LOSS (Laparoscopic Obesity Stimulation Survey) study. Treat Endocrinol. 2006;5:53-58.
148. Cigaina V. Long-term follow-up of gastric stimulation for obesity: the Mestre 8-year experience. Obes Surg. 2004;14(suppl 1):S14-22.
149. Gostout CJ, Rajan E. Endoscopic treatments for obesity: past, present and future. Gastroenterol Clin North Am. 2005;34:143-150.